Six vs 12 Sessions of Gut-focused Hypnotherapy for Irritable Bowel Syndrome: A Randomized Trial
GASTROENTEROLOGY (2021)
期刊
GASTROENTEROLOGY
卷 160, 期 7, 页码 2605-+出版社
W B SAUNDERS CO-ELSEVIER INC
关键词
资金
- National Institute for Health Research Research for Patient Benefit Programme [PB-PG-0906-10134]
- National Institutes of Health Research (NIHR) [PB-PG-0906-10134] Funding Source: National Institutes of Health Research (NIHR)
作者
我是这篇论文的作者
推荐
A Randomized Parallel-group Study of Digital Gut-directed Hypnotherapy vs Muscle Relaxation for Irritable Bowel Syndrome
Sameer K. Berry, Rani Berry, David Recker, Jeffrey Botbyl, Lucy Pun, William D. Chey
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)
Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial
Daniel R. Hoekman, Arine M. Vlieger, Pieter C. Stokkers, Nofel Mahhmod, Svend Rietdijk, Nanne K. de Boer, Tim G. de Meij, Carla Frankenhuis, Geert R. D'Haens, Marc A. Benninga
JOURNAL OF CROHNS & COLITIS (2021)
New multimodal intervention to reduce irritable bowel syndrome (IBS) severity symptoms-Pilot study with a 12 month follow-up
Maximilian Hinse, Anja Thronicke, Anne Berghoefer, Harald Matthes
PLOS ONE (2022)
Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis
Jade Devenney, Syed S. Hasan, Julie Morris, Peter J. Whorwell, Dipesh H. Vasant
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)
Smartphone app-delivered gut-directed hypnotherapy improves symptoms of self-reported irritable bowel syndrome: A retrospective evaluation
Simone. L. L. Peters, Peter. R. R. Gibson, Emma. P. P. Halmos
NEUROGASTROENTEROLOGY AND MOTILITY (2023)
Improving access to gut-directed hypnotherapy for irritable bowel syndrome in the digital therapeutics' era: Are mobile applications a smart solution?
Syed S. Hasan, Sarah Ballou, Laurie Keefer, Dipesh H. Vasant
NEUROGASTROENTEROLOGY AND MOTILITY (2023)
Gut Microbiota Manipulation in Irritable Bowel Syndrome
Tarek Mazzawi
MICROORGANISMS (2022)
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
Lin Xiao, Qin Liu, Mei Luo, Lishou Xiong
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Pain in irritable bowel syndrome: Does anything really help?
Joelle BouSaba, Wassel Sannaa, Michael Camilleri
NEUROGASTROENTEROLOGY AND MOTILITY (2022)
The neurobiology of irritable bowel syndrome
Emeran A. Mayer, Hyo Jin Ryu, Ravi R. Bhatt
MOLECULAR PSYCHIATRY (2023)
Gut microbiome signatures reflect different subtypes of irritable bowel syndrome
Qi Su, Hein M. Tun, Qin Liu, Yun Kit Yeoh, Joyce Wing Yan Mak, Francis K. L. Chan, Siew C. Ng
GUT MICROBES (2023)
Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome
Jenny Lovdahl, Hans Tornblom, Gisela Ringstrom, Olafur S. Palsson, Magnus Simren
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)
Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial
Anthony Lembo, John M. Kelley, Judy Nee, Sarah Ballou, Johanna Iturrino, Vivian Cheng, Vikram Rangan, Jesse Katon, William Hirsch, Irving Kirsch, Kathryn Hall, Roger B. Davis, Ted J. Kaptchuk
PAIN (2021)
Gravity and the Gut: A Hypothesis of Irritable Bowel Syndrome
Brennan Spiegel
AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)
Bile acid-gut microbiota crosstalk in irritable bowel syndrome
Yu Gu, Lingfeng Li, Min Yang, Tianyu Liu, Xueli Song, Xiali Qin, Xin Xu, Jinghua Liu, Bangmao Wang, Hailong Cao
CRITICAL REVIEWS IN MICROBIOLOGY (2023)
Twitter debate: controversies in dysphagia
Aditi Kumar, Gaurav B. Nigam, Dipesh Harshvadan Vasant, Anjan Dhar
FRONTLINE GASTROENTEROLOGY (2023)
Burden of persistent symptoms in treated coeliac disease: cause, aftermath or merely association?
Dipesh H. Vasant
BMJ OPEN GASTROENTEROLOGY (2022)
Regional survey of foundation trainee doctors' views on a career in gastroenterology: implications for diversity and inclusion
Umair Akbani, Dipesh Harshvadan Vasant
FRONTLINE GASTROENTEROLOGY (2023)
Current and future perspectives on the utility of provocative tests of anal sphincter function: A state-of-the-art summary
Alexander O'Connor, Caroline M. Byrne, Dipesh H. Vasant, Abhiram Sharma, Donghua Liao, Niels Klarskov, Edward S. Kiff, Karen Telford
NEUROGASTROENTEROLOGY AND MOTILITY (2023)
Optimising reflux symptom burden and patient compliance during PPI washout periods for oesophageal pH monitoring studies: should we be more proactive with alginate use?
Sophia Agwaonye, Dipesh H. Vasant
BMJ OPEN GASTROENTEROLOGY (2023)
The prevalence and burden of Rome IV faecal incontinence in ulcerative colitis: A cross-sectional study
Dipesh H. Vasant, Gaurav B. Nigam, Sebastian Bate, Shaheen Hamdy, Jimmy K. Limdi
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)
The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study
Hussain Jaafari, Lesley A. Houghton, Robert M. West, Anurag Agrawal, Imran Aziz, Christopher J. Black, Maura Corsetti, Farag Shuweihdi, Maria Eugenicos, Peter A. Paine, Alexander C. Ford, Peter J. Whorwell, Shrikant I. Bangdiwala, Olafur S. Palsson, Ami D. Sperber, Dipesh H. Vasant
NEUROGASTROENTEROLOGY AND MOTILITY (2023)
A comparative study of disorders of gut-brain interaction in Western Europe and Asia based on the Rome foundation global epidemiology study
Johann P. Hreinsson, Reuben K. M. Wong, Jan Tack, Peter Whorwell, Marc A. Benninga, Viola Andresen, Bruno Bonaz, Suck Chei Choi, Enrico S. Corazziari, Javier Santos, Shin Fukudo, Motoyori Kanazawa, Xuicai Fang, Shrikant I. Bangdiwala, Ami D. Sperber, Olafur S. Palsson, Magnus Simren
NEUROGASTROENTEROLOGY AND MOTILITY (2023)
Improving access to gut-directed hypnotherapy for irritable bowel syndrome in the digital therapeutics' era: Are mobile applications a smart solution?
Syed S. Hasan, Sarah Ballou, Laurie Keefer, Dipesh H. Vasant
NEUROGASTROENTEROLOGY AND MOTILITY (2023)
The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study
Huw Purssell, Lucy Bennett, Oliver Street, Karen Piper Hanley, Neil Hanley, Dipesh H. Vasant, Varinder S. Athwal
SCIENTIFIC REPORTS (2023)
The Emerging New Reality of Hypnosis Teletherapy: A Major New Mode of Delivery of Hypnotherapy and Clinical Hypnosis Training
Syed Shariq Hasan, Dipesh Vasant
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL HYPNOSIS (2023)
Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis
Jade Devenney, Syed S. Hasan, Julie Morris, Peter J. Whorwell, Dipesh H. Vasant
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)
The consequences of limited training in disorders of gut-brain interaction: Results from a national survey of gastroenterology trainees in the United Kingdom
Ayodele Sasegbon, Yuying Luo, Laurie A. Keefer, Dipesh H. Vasant
NEUROGASTROENTEROLOGY AND MOTILITY (2023)
Identifying the need for a UK colorectal cancer screening programme for patients with cystic fibrosis (CF): 10-year retrospective review of colonoscopy and colorectal cancer outcomes at a single CF centre
Karuna Sapru, Peter Barry, Andrew Jones, John Walmsley, Javaid Iqbal, Dipesh H. Vasant
BMJ OPEN GASTROENTEROLOGY (2023)